FGF2 and FGFR2 in patients with idiopathic pulmonary fibrosis and lung cancer.

Approximately 2 million patients in developing countries die each year due to LC, and incidence and mortality of LC showed an increasing trend in recent years, and the onset age is becoming increasingly younger ( 2 , 3 ).

also in 63,971 other papers